How Cellarity is uncovering the complexity of human biology and changing the paradigm of classic drug discovery to bring new treatments to patients.
THE TECHNOLOGY, PART 1
More about the company’s unique platform, initial pipeline, and plans moving forward
THE TECHNOLOGY, PART 2
How Cellarity is transforming drug discovery by seeking to understand health and disease at a cellular level rather than looking for molecular targets for medicines.
Chief Scientific Officer Laurens Kruidenier on why we should keep our eyes on the company